adMare BioInnovations Opens Applications for the Spring 2024 Cohort of the BioInnovation Scientist Program: Foundations and Launches New Biopharma Industry Essentials Program
Thryv Therapeutics Presents Benefits of Therapeutic SGK1 Inhibition with THRV-1268 in a Murine Model of Atrial Fibrillation at American Heart Association Scientific Sessions